These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 33614398)

  • 1. COVID-19: Diagnostics, Therapeutic Advances, and Vaccine Development.
    Majid S; Khan MS; Rashid S; Niyaz A; Farooq R; Bhat SA; Wani HA; Qureshi W
    Curr Clin Microbiol Rep; 2021; 8(3):152-166. PubMed ID: 33614398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses.
    Majid S; Farooq R; Khan MS; Rashid S; Bhat SA; Wani HA; Qureshi W
    SN Compr Clin Med; 2020; 2(10):1767-1776. PubMed ID: 32864575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight.
    He C; Qin M; Sun X
    Acta Pharm Sin B; 2020 Jul; 10(7):1175-1191. PubMed ID: 32834948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside Inhibitors of Coronaviruses.
    Zenchenko AA; Drenichev MS; Mikhailov SN
    Curr Med Chem; 2021; 28(26):5284-5310. PubMed ID: 33563148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection.
    Bhatti JS; Bhatti GK; Khullar N; Reddy AP; Reddy PH
    Mol Neurobiol; 2020 Nov; 57(11):4856-4877. PubMed ID: 32808122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Therapeutics and Vaccines: A Race to Save Lives.
    Bebenek I; Bannister R; Dubinion J; Fortin M; Liu M; Motter AL; Rohde CM; Wrzesinski C
    Toxicol Sci; 2022 Jan; 185(2):119-127. PubMed ID: 34735018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact.
    Sood S; Aggarwal V; Aggarwal D; Upadhyay SK; Sak K; Tuli HS; Kumar M; Kumar J; Talwar S
    Curr Pharmacol Rep; 2020; 6(5):212-227. PubMed ID: 32837855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The COVID-19 puzzle: a global nightmare.
    Mahrosh HS; Mustafa G
    Environ Dev Sustain; 2021; 23(9):12710-12737. PubMed ID: 33551672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants.
    Yin J; Li C; Ye C; Ruan Z; Liang Y; Li Y; Wu J; Luo Z
    Comput Struct Biotechnol J; 2022; 20():824-837. PubMed ID: 35126885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.